; age at entry (5-year age groups); blood in post (0-1,2, ≥3 days, not known); years breast cancer-free in study (0-6); body mass index, kg/m2 (continuous); parity (nulliparous; age at first birth<25y/1-2 children; age at first birth<25y/≥3 children; age at first birth 25-29y/1-2 children; age at first birth 25-29y/≥3 children; age at first birth ≥30y/1-4 children); family history of breast cancer (yes, no); age at menarche (≤12, 13,14,15-20, not known); age at menopause (<45, 45-49, 50-54, ≥55, not known); years of postmenopausal hormone therapy (never, <2. 2-5, 6-9, ≥10, not known); alcohol units (0, <5, 5-14, ≥15 grams per day, not known) (d) Adjustment for (c) and quartile of respective sex hormone or SHBG level and laboratory batch (b) Covariates: year of entry to the study (≤2005, 2006, 2007, ≥2008) ; age at entry (5-year age groups); blood in post (0-1,2, ≥3 days, not known); years breast cancer free in study (0-6); body mass index, kg/m2 (continuous); parity (nulliparous; age at first birth<25y/1-2 children; age at first birth<25y/≥3 children; age at first birth 25-29y/1-2 children; age at first birth 25-29y/≥3 children; age at first birth ≥30y/1-4 children); family history of breast cancer (yes, no); age at menarche (≤12, 13,14,15-20, not known); age at menopause ((<45, 45-49, 50- 
